Sanguine Biosciences Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 120

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 22

Sanguine Biosciences General Information

Description

Developer of a translational biomedical and biospecimen collection platform designed for research purposes. The company's platform offers direct-to-patient engagement, in-home collection of annotated biospecimens and apheresis product offerings, enabling researchers to access and conduct prospective study designs and obtain clinically relevant biomarker data.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3030 Bunker Hill Street
  • Suite 119
  • San Diego, CA 92109
  • United States
+1 (855)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Other Healthcare Services
Corporate Office
  • 3030 Bunker Hill Street
  • Suite 119
  • San Diego, CA 92109
  • United States
+1 (855)

Sanguine Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanguine Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 15-Aug-2024 Completed Generating Revenue
10. Debt - General 31-Oct-2023 Completed Generating Revenue
9. Later Stage VC 09-Jan-2023 Completed Generating Revenue
8. Secondary Transaction - Private 16-Mar-2022 Completed Generating Revenue
7. Debt - PPP 08-Apr-2020 Completed Generating Revenue
6. Grant 01-Feb-2019 Completed Generating Revenue
5. Accelerator/Incubator 18-Mar-2018 Completed Generating Revenue
4. Later Stage VC 01-Jul-2016 Completed Generating Revenue
3. Later Stage VC (Series A) 29-May-2015 $5.53M $7.03M Completed Startup
2. Seed Round 21-Feb-2013 $1.5M $1.5M Completed Startup
To view Sanguine Biosciences’s complete valuation and funding history, request access »

Sanguine Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Sanguine Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sanguine Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a translational biomedical and biospecimen collection platform designed for research purposes. The company'
Other Healthcare Technology Systems
San Diego, CA
120 As of 2025

Beverly, MA
 

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sanguine Biosciences Competitors (2)

One of Sanguine Biosciences’s 2 competitors is Genomic Expression, a Venture Capital-Backed company based in Beverly, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomic Expression Venture Capital-Backed Beverly, MA
Asuragen Formerly VC-backed Austin, TX
You’re viewing 2 of 2 competitors. Get the full list »

Sanguine Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sanguine Biosciences Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Albany Capital (Australia) Venture Capital Minority
BroadOak Capital Partners Growth/Expansion Minority
Catalio Capital Management Venture Capital Minority
Vitamin Capital Venture Capital Minority
Neman Ventures Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

Sanguine Biosciences FAQs

  • When was Sanguine Biosciences founded?

    Sanguine Biosciences was founded in 2010.

  • Where is Sanguine Biosciences headquartered?

    Sanguine Biosciences is headquartered in San Diego, CA.

  • What is the size of Sanguine Biosciences?

    Sanguine Biosciences has 120 total employees.

  • What industry is Sanguine Biosciences in?

    Sanguine Biosciences’s primary industry is Other Healthcare Technology Systems.

  • Is Sanguine Biosciences a private or public company?

    Sanguine Biosciences is a Private company.

  • What is Sanguine Biosciences’s current revenue?

    The current revenue for Sanguine Biosciences is .

  • How much funding has Sanguine Biosciences raised over time?

    Sanguine Biosciences has raised $27.5M.

  • Who are Sanguine Biosciences’s investors?

    Albany Capital (Australia), BroadOak Capital Partners, Catalio Capital Management, Vitamin Capital, and Neman Ventures are 5 of 22 investors who have invested in Sanguine Biosciences.

  • Who are Sanguine Biosciences’s competitors?

    Genomic Expression and Asuragen are competitors of Sanguine Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process